Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» UCB-Amgen Reveals Positive Data on Romosozumab for PMO
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Submitted by
admin
on September 18, 2014 - 9:17am
Source:
Yahoo/Zacks.com
News Tags:
Amgen
UCB Pharmaceuticals
romosozumab
low bone mineral density
Headline:
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Do Not Allow Advertisers to Use My Personal information
